These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 101819

  • 1. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
    Böhme H, Schmidt P, Hüttel E.
    MMW Munch Med Wochenschr; 1978 Nov 10; 120(45):1501-4. PubMed ID: 101819
    [Abstract] [Full Text] [Related]

  • 2. [Clinical experience with Arwin (author's transl)].
    Hess H, Keil-Kuri E, Marshall M.
    MMW Munch Med Wochenschr; 1975 Aug 08; 117(32-33):1317-20. PubMed ID: 819792
    [Abstract] [Full Text] [Related]

  • 3. [Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
    Heidrich H.
    Med Klin; 1978 May 26; 73(21):798-800. PubMed ID: 651769
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Pharmacological treatment of chronic arterial occlusive disease (author's transl)].
    Dittrich J, Spaan G, Stein U, Wagner E, Frese JH.
    Med Klin; 1979 Sep 28; 74(39):1396-403. PubMed ID: 492058
    [Abstract] [Full Text] [Related]

  • 9. [Defibrination with ancrod (arvin) in peripheral arterial occlusive diseases. Principle, indications, contraindications technic and course].
    Heidrich H.
    ZFA (Stuttgart); 1978 Nov 20; 54(32):1648-51. PubMed ID: 735320
    [No Abstract] [Full Text] [Related]

  • 10. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
    Ehrly AM.
    Med Welt; 1975 Mar 07; 26(10):446-55. PubMed ID: 1123988
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term results after defibrinogenation by Arwin in chronic occlusive arterial disease.
    Staiger J, Konrad-Graf S, Keil G.
    Bibl Haematol; 1981 Mar 07; (47):252-7. PubMed ID: 7337665
    [No Abstract] [Full Text] [Related]

  • 14. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E.
    MMW Munch Med Wochenschr; 1983 Sep 16; 125(37):796-8. PubMed ID: 6415441
    [No Abstract] [Full Text] [Related]

  • 15. [Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
    Heidrich H.
    ZFA (Stuttgart); 1981 Apr 10; 57(10):742-50. PubMed ID: 6165157
    [No Abstract] [Full Text] [Related]

  • 16. [Modified dosage scheme for the subcutaneous use of arvin in patients with chronic arterial occlusive diseases].
    Ehrly AM, Köhler HJ.
    Vasa; 1976 Apr 10; 5(2):155-62. PubMed ID: 973426
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Quantitative analysis of fibrinmonomer in Arwin-therapy (author's transl)].
    Rath NF, Wuppermann T.
    Blut; 1978 Jan 20; 36(1):9-14. PubMed ID: 623920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.